- Home
- BMBL vs ZVRA Comparison
BMBL vs ZVRA Comparison
Compare BMBL & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMBL | ZVRA |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 545.0M | 499.9M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BMBL | ZVRA |
|---|---|---|
| Price | $3.41 | $8.18 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | $5.08 | ★ $21.71 |
| AVG Volume (30 Days) | ★ 2.9M | 1.2M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | ★ $1,003,141,000.00 | $84,388,000.00 |
| Revenue This Year | N/A | $333.25 |
| Revenue Next Year | N/A | $43.70 |
| P/E Ratio | ★ N/A | $15.50 |
| Revenue Growth | N/A | ★ 244.60 |
| 52 Week Low | $3.18 | $6.19 |
| 52 Week High | $8.82 | $13.16 |
Technical Indicators
Market Signals| Indicator | BMBL | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 32.77 | 36.66 |
| Support Level | $3.57 | $8.12 |
| Resistance Level | $3.90 | $9.03 |
| Average True Range (ATR) | 0.18 | 0.35 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 13.91 | 3.85 |
Price Performance
Historical ComparisonAbout BMBL Bumble Inc.
Bumble Inc is engaged in offering online dating services. The platform enables people to connect and build healthy and equitable relationships on their own terms. The company operates two apps, Bumble and Badoo, where users come every month to discover new people and connect. The company Operates in USA and also Internationally such as United Kingdom, Czech Republic, and others with maximum of revenue from Other Countries.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.